VACSERA

About Us

A Century of Service to Public Health

Starting as Egypt's first biological laboratory, VACSERA has evolved into a national biomanufacturing champion safeguarding public health.

VACSERA Facility

Vision

Achieving leadership in the field of production, development and marketing of biological preparations, serums, human and veterinary vaccines and blood derivatives for local and regional markets, and keeping pace with rapid technological progress in order to improve competitiveness at the global level.

Mission

Contribute to secure the country's needs of human and veterinary vaccines, bio-technological medicines, blood and its derivatives, reagents and medical supplies by raising the efficiency of local production and preserving the rights of the company's employees.

Leadership

Prof. Dr. Sherif El-Fil

Dr. Sherif El-Fil

Executive Managing Director of the Holding Company for Biological Products and Vaccines

VACSERA's investments in localizing vaccine production in Egypt, research and development, infrastructure, and workforce development embody a sustainable future vision for healthcare, ensuring Egypt’s current and future needs. It contributes to building a healthcare system that creates a legacy for future generations and supports the vaccine industry from its early stages, enhancing access to high-quality vaccines across the Middle East and Africa.

Corporate Governance

VACSERA Board of Directors

Distinguished scientific and executive leaders steering the national strategy for vaccine localization and biomanufacturing.

Non-executive Chairman

Prof. Dr. Awad Khalil

Executive Managing Director

Prof. Dr. Sherif El-Fil

Non-executive board members

Prof. Dr. Ashraf Mansour

Board Member

Prof. Dr. Mohamed Kandil

Board Member

Prof. Dr. Tarek Marzouk

Board Member

Prof. Dr. Mohamed Farouk

Board Member

Prof. Dr. Atef El-Awam

Board Member

Mr. Ahmed Sayed Hassan

Board Member

Mr. Ali Abdel Basit

Board Member

Certificates & Accreditations

Committed to the highest global quality and safety benchmarks in biological production.

Certificate Logo

WHO GMP Compliance

Adhering to the World Health Organization guidelines for sterile biological production.

Certificate Logo

ISO 9001:2015

International standard for premium Quality Management System across all processes.

Certificate Logo

ISO 14001:2015

Environmental Management System supporting green and sustainable bio-industrial operations.

Certificate Logo

ISO 45001:2018

Occupational Health and Safety management keeping our biological research staff safe.

Certificate Logo

IRB Registration Certificate

Institutional Review Board Accreditation

Certificate Logo

CRE Registration Certificate

Supreme Council of Research Ethics — August 2025

Our History

Our timeline of scientific achievements and expansion.

●
1881

Establishment of a small laboratory under the Health Department

●
1893

First production of smallpox vaccine in Egypt

●
1897

Establishment of the General Administration of Laboratories

●
1907

First production of rabies vaccine

●
1939

Establishment of laboratories in Agouza for production of smallpox, typhoid, and tetanus vaccines

●
1940

Establishment of Fouad I Laboratory for Serum and Vaccine in Agouza

●
1947

Addition of King Farouk Laboratory for Biological Products and production of cholera vaccine

●
1948

Establishment of the first central blood bank in Egypt and a laboratory animal farm in Agouza

●
1968

Establishment of the animal breeding farm in Helwan

●
1972

Establishment of the Egyptian General Authority for Biological Products & Vaccines in Agouza

●
1979

Transformation into an economic public authority (Decree No. 1039)

●
2002

Transformation into a Holding Company with 5 subsidiaries (Presidential Decree No. 187/2002)

●
2006-2007

Re-evaluation and merger of subsidiaries to form 3 core subsidiary companies

Frequently Asked Questions

Scientific and verified answers to common inquiries.